Details for New Drug Application (NDA): 214869
✉ Email this page to a colleague
The generic ingredient in DHIVY is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.
Summary for 214869
Tradename: | DHIVY |
Applicant: | Avion Pharms |
Ingredient: | carbidopa; levodopa |
Patents: | 3 |
Suppliers and Packaging for NDA: 214869
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DHIVY | carbidopa; levodopa | TABLET;ORAL | 214869 | NDA | Avion Pharmaceuticals, LLC | 75854-701 | 75854-701-01 | 100 TABLET in 1 BOTTLE (75854-701-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG;100MG | ||||
Approval Date: | Nov 12, 2021 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 28, 2039 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | METHOD OF TREATING PARKINSON'S DISEASE BY ORALLY ADMINISTERING A FUNCTIONALLY MULTISCORED, BILAYERED TABLET HAVING CARBIDOPA—25 MG/LEVODOPA—100 MG | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 28, 2039 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | METHOD OF TREATING PARKINSON'S DISEASE BY ORALLY ADMINISTERING SEGMENTS OF A FUNCTIONALLY MULTISCORED, BILAYERED TABLET HAVING CARBIDOPA—25 MG/LEVODOPA—100 MG, EACH SEGMENT HAVING CARBIDOPA—6.25 MG/LEVODOPA—25 MG | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 28, 2039 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF PARKINSON'S DISEASE |
Complete Access Available with Subscription